Genfit Stock Market Invest

GENFIT Announces Positive EMA Opinion on Iqirvo® for Primary Biliary Cholangitis Jul 26, 2024

GENFIT Anticipates Investor Attention with 2024 Financial Calendar Announcement Jan 15, 2024

GENFIT Highlights NIS2+™ as a Potent Screening Tool in Liver Disease Clinical Trials Dec 7, 2023